Table 3 Annual changes in the proportions of MDROs(2015–2020)
MDRO | Strains (%) | ||||||
|---|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | |
Carbapenem-Resistant Enterobacteriaceae(CRE) | 27 (34.18) | 79 (60.77) | 11 (15.07) | 55 (38.73) | 21 (27.92) | 25(29.76) | 218(37.20) |
Methicillin-Resistant Staphylococcus aureus (MRSA) | 9 (11.39) | 9 (6.92) | 25 (34.25) | 20 (14.08) | 21 (26.92) | 23 (27.38) | 107(18.26) |
Carbapenem-Resistant Pseudomonas aeruginosa(CRPA) | 20 (25.32) | 22 (6.92) | 21 (28.78) | 22 (15.49) | 19 (24.36) | 20 (23.81) | 124(21.16) |
Carbapenem-Resistant Acinetobacter baumannii(CRAB) | 22 (27.85) | 11 (8.46) | 12 (16.45) | 44 (30.99) | 17 (21.79) | 15 (17.86) | 121(20.65) |
Vancomycin-Resistant Enterococcus (VRE) | 1 (1.27) | 9 (6.92) | 4 (5.48) | 1 (0.70) | 0 (0.00) | 1(1.19) | 16(2.73) |
Total | 79 (23.09) | 130 (100.00) | 73 (100.00) | 142 (100.00) | 78 (100.00) | 84 (100.00) | 586(100.00) |